Synonyms: IRL790
Compound class:
Synthetic organic
Comment: Mesdopetam (IRL790) is an experimental small molecule compound with psychomotor stabilizing properties. The primary target is the dopamine D3 receptor, a target implicated in the generation of levodopa-induced dyskinesia, a side-effect frequently occurring with long-term levodopa treatment in patients with Parkinson's disease.
|
|
No information available. |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT03368170 | Efficacy and Tolerability of IRL790 in Parkinson's Disease Dyskinesia | Phase 2 Interventional | Integrative Research Laboratories AB |